Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Hospital Blueprint of the Future. Part 1 of 2.

The pandemic forever changed the way we engage with healthcare, but the road to change was a long time coming. While exasperated by the pandemic, the way people interact with healthcare was already big on virtual visits and connected infrastructure. The hospital of the future is already here, so what does that look like, how…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The pandemic forever changed the way we engage with healthcare, but the road to change was a long time coming. While exasperated by the pandemic, the way people interact with healthcare was already big on virtual visits and connected infrastructure. The hospital of the future is already here, so what does that look like, how do current standards react to this change, and how do new technologies keep it evolving?

On this episode of Healthcare on Air by Verizon, host Lea Sims spoke with guests Danny Johnson and Gary Lynch about the hospital of the future and what it looks like. While Johnson looks at how Verizon’s 5G technology can be used for more interconnectivity between sectors, Lynch focuses on major market trends. They understand that private networks, private 5G, edge computing, and core security are important to the new ways hospitals are running.

“Looking at what happened in the pandemic, where are providers focused? They’ve moved to being more patient centric, right?” said Lynch, regarding the vision of the hospital of the future. “I’m putting the patient at the center of the universe and kind of building their services and solutions around it. We’re moving more virtual, more care moving out of the four walls of the hospital into the home, more ambulatory.”

This episode also covers:

  • The physical and virtual environment of hospitals and healthcare
  • Changing technologies within healthcare
  • How new technology can be implemented into established legacy hospitals

Lynch noted that some hospitals remained profitable and functionable during the pandemic, thanks to going virtual. This is part of why the hospital of the future is very much the hospital of the present, as many hospitals and healthcare facilities are using this technology successfully. “This hospital of the future has kind of evolved into this really ‘ecosystem of the future,’ if you will.”

Danny Johnson is the Director of Product Marketing at Verizon, focusing on 5G, MEC, IoT, SDN, and next generation services. Gary Lynch is the Global Practice Lead of Healthcare and Life Sciences at Verizon, having first started as their Managing Partner of Global Solutions for Healthcare and Life Sciences Vertical.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Physician burnout stems not just from workload but from loss of meaningful voice in healthcare organizations. Dr. Krishna Vedala discusses how primary care is mismanaged as a procedural business, how AI should free physicians from administrative work rather than replace them, and why physicians may need collective representation to restore trust between clinicians and administrators.

  • 01Physicians increasingly lack meaningful participation in organizational decisions, despite being closest to patients and responsible for care delivery.
  • 02Primary care requires complex, nuanced decision-making but is often managed with productivity expectations designed for procedural specialties, pushing work home and some physicians toward breaking point.
  • 03AI's highest value is reducing administrative burden and documentation so physicians have more time with patients, not replacing clinical judgment or human relationships.

Sep 8, 2026

MRI segmentation models can now label 80 structures, but deployment is the hard part

MRI segmentation models can now label 80 structures. TotalSegmentator MRI is an nnU-Net model that provides rapid segmentation of all major organs across all MRI sequences, according to Radiology Business. For health systems, deployment is the hard part.

  • 01The spread between 0.97 Dice on lungs and 0.54 on portal and splenic veins in MRSegmentator is the real operational story: enterprises need confidence flags and escalation paths, not a single headline score.
  • 02Hospitals planning radiation oncology and neuro volumetry programs can treat segmentation speedups as capacity gains only if downstream steps, contour review, dose planning inputs, and reporting templates, are standardized.

Sep 8, 2026

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512